Skip to main content
Skip to main navigation
National Institute for Public Health and the Environment
Ministry of Health, Welfare and Sport
Nederlands
English
RIVM
Committed to
health and sustainability
Menu
expand
Home
Topics
About RIVM
Publications
International
Contact
Agenda
Nederlands
English
Search form expand
Search
Search
Home
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties.
Date Published
16-12-2019
Identifiers
Accession Number
2019668
Remaining
Open Access
Yes